500 total citations 16 papers, 423 citations indexed
About
Capizzi Rl is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Oncology.
According to data from OpenAlex, Capizzi Rl has authored 16 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Public Health, Environmental and Occupational Health, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Capizzi Rl's work include Acute Lymphoblastic Leukemia research (5 papers), Acute Myeloid Leukemia Research (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Capizzi Rl is often cited by papers focused on Acute Lymphoblastic Leukemia research (5 papers), Acute Myeloid Leukemia Research (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Capizzi Rl collaborates with scholars based in United States. Capizzi Rl's co-authors include Frederick Richards, Cooper Mr, Matthew Poole, Spurr Cl, Muss Hb, Sartorelli Ac, Clifton R. White, White Jc, Declan Delaney and Jesse C. Craig and has published in prestigious journals such as Leukemia, PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).
In The Last Decade
Capizzi Rl
16 papers
receiving
398 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Capizzi Rl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Capizzi Rl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Capizzi Rl more than expected).
This network shows the impact of papers produced by Capizzi Rl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Capizzi Rl. The network helps show where Capizzi Rl may publish in the future.
Co-authorship network of co-authors of Capizzi Rl
This figure shows the co-authorship network connecting the top 25 collaborators of Capizzi Rl.
A scholar is included among the top collaborators of Capizzi Rl based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Capizzi Rl. Capizzi Rl is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
16 of 16 papers shown
1.
Rl, Capizzi. (1999). Clinical status and optimal use of amifostine.. PubMed. 13(1). 47–59; discussion 63, 67.43 indexed citations
2.
Rl, Capizzi. (1999). The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine.. PubMed. 26(2 Suppl 7). 3–21.124 indexed citations
3.
Jc, White, et al.. (1991). S-phase fraction is not correlated with nucleoside transport in acute myeloid leukemia cells.. PubMed. 5(7). 598–601.6 indexed citations
4.
Jc, White, et al.. (1991). Leukapheresis induced changes in cell cycle distribution and nucleoside transporters in patients with untreated acute myeloid leukemia.. Leukemia. 5(12). 1037–42.12 indexed citations
5.
Rl, Capizzi, et al.. (1990). Correlation of the proliferative index of residual leukemia with outcome in patients treated with sequential high dose ara-C and asparaginase.. PubMed. 4(5). 316–20.2 indexed citations
6.
Richards, Frederick, et al.. (1989). Chemoinfusion of the hepatic artery for metastases to the liver.. PubMed. 168(4). 291–5.3 indexed citations
7.
Rl, Capizzi, et al.. (1988). Low dose Ara-C for patients with myelodysplastic syndromes.. PubMed. 2(3). 153–6.17 indexed citations
8.
Rl, Capizzi & Clifton R. White. (1988). The pharmacologic basis for the efficacy of high-dose Ara-C and sequential asparaginase in adult acute myelogenous leukemia.. PubMed. 61(1). 11–22.5 indexed citations
9.
Lr, Smith, et al.. (1987). Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association Study.. PubMed. 71(2). 151–3.6 indexed citations
10.
Je, Richter, et al.. (1986). Cure of hepatic candidiasis in acute leukemia.. PubMed. 47(9). 393–5.1 indexed citations
11.
Rl, Capizzi, et al.. (1985). Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies.. PubMed. 12(2 Suppl 3). 166–70.6 indexed citations
12.
Rl, Capizzi, Matthew Poole, Cooper Mr, et al.. (1984). Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase.. PubMed. 63(3). 694–700.159 indexed citations
13.
Rl, Comis, et al.. (1983). Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ).. PubMed. 67(1). 95–6.2 indexed citations
14.
Rl, Capizzi, et al.. (1982). Randomized phase II comparison of methotrexate with or without L-asparaginase in non-small cell cancer of the lung.. PubMed. 66(3). 541–4.3 indexed citations
15.
Rl, Capizzi. (1977). The place of pharmacology in cancer medicine.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 4(2). 131–3.5 indexed citations
16.
Rl, Capizzi, et al.. (1977). Combination chemotherapy--theory and practice.. PubMed. 4(2). 227–53.29 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.